Insider · CIK 0001792310
Assaf Oron
Files at HLSQ (BiomX Inc.). First filing Dec 1, 2023, latest Dec 1, 2023.
In brief
Assaf Oron files SEC Form 4 as officer at HLSQ (BiomX Inc.). Since Dec 1, 2023, Assaf Oron has reported 0 open-market buys worth $0 and 1 open-market sell worth $4,072, the latest filed on Dec 1, 2023.
A track record needs three past buys with six months of prices behind them; Assaf Oron has 0, so none is measured yet.
The newest scored trade: sold $4,072 of HLSQ on Nov 29, 2023, filed Dec 1, 2023, scored 35 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
HLSQ: BiomX Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | HLSQsell BiomX Inc. | $4,072 10,914 shares | -100% | +122% from low-51% from high |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 11, 2023 | HLSQ BiomX Inc. | DDisposition to issuer Common Stock Options - Right to Buyderivative | -31,500 | - | - | 0 | Dec 13, 2023 |
| Dec 11, 2023 | HLSQ BiomX Inc. | AGrant or award Common Stock Options - Right to Buyderivative | +8,290 | - | - | 8,290 | Dec 13, 2023 |
| Dec 11, 2023 | HLSQ BiomX Inc. | DDisposition to issuer Common Stock Options - Right to Buyderivative | -33,250 | - | - | 0 | Dec 13, 2023 |
| Dec 11, 2023 | HLSQ BiomX Inc. | AGrant or award Common Stock Options - Right to Buyderivative | +8,750 | - | - | 8,750 | Dec 13, 2023 |
| Nov 29, 2023 | HLSQ BiomX Inc. | SOpen-market sale Common Stock | -5,444 | $0.40 | $2,178 | 5,470 | Dec 1, 2023 |
| Nov 29, 2023 | HLSQ BiomX Inc. | SOpen-market sale Common Stock | -3,414 | $0.35 | $1,195 | 2,056 | Dec 1, 2023 |
| Nov 29, 2023 | HLSQ BiomX Inc. | SOpen-market sale Common Stock | -2,056 | $0.34 | $699 | 0 | Dec 1, 2023 |
| Oct 29, 2023 | HLSQ BiomX Inc. | DDisposition to issuer Common Stock Options - Right to Buyderivative | -155,363 | $0.00 | $0 | 0 | Oct 31, 2023 |
| Oct 29, 2023 | HLSQ BiomX Inc. | AGrant or award Common Stock Options - Right to Buyderivative | +155,363 | $0.00 | $0 | 0 | Oct 31, 2023 |
| Oct 29, 2023 | HLSQ BiomX Inc. | DDisposition to issuer Common Stock Options - Right to Buyderivative | -82,667 | $0.00 | $0 | 0 | Oct 31, 2023 |
| Oct 29, 2023 | HLSQ BiomX Inc. | AGrant or award Common Stock Options - Right to Buyderivative | +82,667 | $0.00 | $0 | 0 | Oct 31, 2023 |
| Oct 29, 2023 | HLSQ BiomX Inc. | DDisposition to issuer Common Stock Options - Right to Buyderivative | -46,966 | $0.00 | $0 | 0 | Oct 31, 2023 |
| Oct 29, 2023 | HLSQ BiomX Inc. | AGrant or award Common Stock Options - Right to Buyderivative | +46,966 | $0.00 | $0 | 0 | Oct 31, 2023 |
Questions about Assaf Oron
Answered from the filings on this page, as of the latest one.
Is Assaf Oron buying or selling?
Not in the last 12 months. Assaf Oron's latest open-market trade on SEC Form 4 was sold $4,072 of HLSQ on Nov 29, 2023.
How did Assaf Oron's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Assaf Oron has 0.
Where does Assaf Oron file Form 4?
Assaf Oron has filed Form 4 at HLSQ (BiomX Inc.) as Chief Business Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.